Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Practical Acute Myeloid Leukemia (AML) Biomarker Testing Using Next-Generation Sequencing (NGS) Technology: A Comprehensive, Rapid, Inexpensive and Flexible Approach

Rebecca F McClure, MD, Tyler Kirwan, Zachary Castonguay, Amanda Marolt, Michael Rutherford, MD

Blood (2015) 126 (23): 4973.

https://doi.org/10.1182/blood.V126.23.4973.4973

Published: 2015

Journal Articles

A Phase-2 Trial of Low-Dose Pomalidomide In Myelofibrosis with Anemia

Kebede Begna, MD, Ruben A. Mesa, MD, Animesh Pardanani, MBBS, PhD, William J Hogan, MBBCh, Mark R. Litzow, MD, Rebecca F McClure, MD, Ayalew Tefferi, MD

Blood (2010) 116 (21): 4109.

https://doi.org/10.1182/blood.V116.21.4109.4109

Published: 2010

Journal Articles

Choosing the Right Patients for Clinical Trials in Essential Thrombocythemia or Polycythemia Vera: Leukemic or Fibrotic Transformation Risk Assessment among 1061 Patients from a Single Institution.

Ayalew Tefferi, MD, Naseema Gangat, MD, Alexandra P. Wolanskyj, MD, Susan M. Schwager, Animesh Pardanani, MD, PhD, Ruben A. Mesa, MD, Rebecca F. McClure, MD, Chin-Yang Li, MD, Curtis A. Hanson, MD

Blood (2007) 110 (11): 3546.

https://doi.org/10.1182/blood.V110.11.3546.3546

Published: 2007

Journal Articles

Risk Stratification for Survival and Leukemic Transformation in Essential Thrombocythemia: A Single Institutional Study of 605 Patients.

Naseema Gangat, MBBS, Alexandra Wolanskyj, MD, Rebecca F. McClure, MD, Chin Y. Li, MD, Susan M. Schwager, Wenting Wu, PhD, Ayalew Tefferi, MD

Blood (2006) 108 (11): 3599.

https://doi.org/10.1182/blood.V108.11.3599.3599

Published: 2006

Journal Articles

JAK2 V617F Mutation in Essential Thrombocythemia: Clinical Associations and Long-Term Prognostic Relevance.

Alexandra P. Wolanskyj, MD, Terra L. Lasho, MT, ASCP, Susan M. Schwager, Rebecca F. McClure, MD, Martha Wadleigh, MD, Stephanie J. Lee, MD, D. Gary Gilliland, MD, PhD, Ayalew Tefferi, MD

Blood (2005) 106 (11): 254.

https://doi.org/10.1182/blood.V106.11.254.254

Published: 2005

Journal Articles

Lenalidomide (CC-5013) Treatment for Anemia Associated with Myelofibrosis with Myeloid Metaplasia.

Ayalew Tefferi, MD, Ruben A. Mesa, MD, William J. Hogan, MD, Trudy A. Shaw, Gayle E. Reyes, Jacob B. Allred, Cynthia X. Ma, MD, Grace K. Dy, MD, Alexandra P. Wolanskyj, MD, Mark L. Litzow, MD, David P. Steensma, MD, Timothy G. Call, MD, Rebecca F. McClure, MD

Blood (2005) 106 (11): 2583.

https://doi.org/10.1182/blood.V106.11.2583.2583

Published: 2005

Journal Articles

A Phase II Study of CC-5013 Treatment for Myelofibrosis with Myeloid Metaplasia: A Preliminary Report.

Ayalew Tefferi, MD, William J. Hogan, MD, Alexandra P. Wolanskyj, MD, Trudy A. Shaw, Gayle E. Reyes, Antje Hoering, PhD, Rebecca F. McClure, MD, Ruben A. Mesa, MD

Blood (2004) 104 (11): 1505.

https://doi.org/10.1182/blood.V104.11.1505.1505

Published: 2004

NARROW

Practical Acute Myeloid Leukemia (AML) Biomarker Testing Using Next-Generation Sequencing (NGS) Technology: A Comprehensive, Rapid, Inexpensive and Flexible Approach

A Phase-2 Trial of Low-Dose Pomalidomide In Myelofibrosis with Anemia

Choosing the Right Patients for Clinical Trials in Essential Thrombocythemia or Polycythemia Vera: Leukemic or Fibrotic Transformation Risk Assessment among 1061 Patients from a Single Institution.

Risk Stratification for Survival and Leukemic Transformation in Essential Thrombocythemia: A Single Institutional Study of 605 Patients.

JAK2 V617F Mutation in Essential Thrombocythemia: Clinical Associations and Long-Term Prognostic Relevance.

Lenalidomide (CC-5013) Treatment for Anemia Associated with Myelofibrosis with Myeloid Metaplasia.

A Phase II Study of CC-5013 Treatment for Myelofibrosis with Myeloid Metaplasia: A Preliminary Report.

Email alerts

ASH Publications

American Society of Hematology

Practical Acute Myeloid Leukemia (AML) Biomarker Testing Using Next-Generation Sequencing (NGS) Technology: A Comprehensive, Rapid, Inexpensive and Flexible Approach

A Phase-2 Trial of Low-Dose Pomalidomide In Myelofibrosis with Anemia

Choosing the Right Patients for Clinical Trials in Essential Thrombocythemia or Polycythemia Vera: Leukemic or Fibrotic Transformation Risk Assessment among 1061 Patients from a Single Institution.

Risk Stratification for Survival and Leukemic Transformation in Essential Thrombocythemia: A Single Institutional Study of 605 Patients.

JAK2 V617F Mutation in Essential Thrombocythemia: Clinical Associations and Long-Term Prognostic Relevance.

Lenalidomide (CC-5013) Treatment for Anemia Associated with Myelofibrosis with Myeloid Metaplasia.

A Phase II Study of CC-5013 Treatment for Myelofibrosis with Myeloid Metaplasia: A Preliminary Report.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only